Showing results (111-120 of 253) with videos related to

Sort By:
Pageof 26
Frontiers in Immunology|May 19, 2023
Potential causal role of synovial complement system activation in the development of post-traumatic osteoarthritis after anterior cruciate ligament injury or meniscus tearV Michael Holers, Rachel M Frank, Andrew Clauw, et al.
Rheumatology International|October 3, 2015
Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass indexRichard J Reynolds, Ana I Vazquez, Vinodh Srinivasasainagendra, et al.
Arthritis and Rheumatism|July 13, 2002
Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusionLarry W Moreland, Rieke Alten, Filip Van den Bosch, et al.
Genetic Epidemiology|May 17, 2021
A novel Mendelian randomization method with binary risk factor and outcomePhilip H Allman, Inmaculada Aban, Dustin M Long, et al.
Immune Network|May 10, 2024
Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament InjuryV Michael Holers, Rachel M Frank, Michael Zuscik, et al.
Annals of the Rheumatic Diseases|November 8, 2015
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisTheresa Wampler Muskardin, Priyanka Vashisht, Jessica M Dorschner, et al.
Current Rheumatology Reports|July 29, 2010
Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?Maria I Danila, Laura B Hughes, Elizabeth E Brown, et al.
International Journal of Rheumatology|July 31, 2012
Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Karina I Halilova, Elizabeth E Brown, Sarah L Morgan, et al.
Arthritis and Rheumatism|January 16, 2003
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trialMichael E Weinblatt, Edward C Keystone, Daniel E Furst, et al.
The Journal of Rheumatology|February 17, 2006
Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind studyAlyssa K Johnsen, Michael H Schiff, Philip J Mease, et al.
Pageof 26